Literature DB >> 29042489

Alterations in endothelin type B receptor contribute to microvascular dysfunction in women who have had preeclampsia.

Anna E Stanhewicz1, Sandeep Jandu2, Lakshmi Santhanam2, Lacy M Alexander3.   

Abstract

Microvascular dysfunction originating during a preeclamptic pregnancy persists postpartum and probably contributes to increased CVD risk in these women. One putative mechanism contributing to this dysfunction is increased vasoconstrictor sensitivity to endothelin-1 (ET-1), mediated by alterations in ET-1 receptor type-B (ETBR). We evaluated ET-1 sensitivity, ETAR, and ETBR contributions to ET-1-mediated constriction, and the mechanistic role of ETBR in endothelium-dependent dilation in vivo in the microvasculature of postpartum women who had preeclampsia (PrEC, n=12) and control women who had a healthy pregnancy (HC, n=12). We hypothesized that (1) PrEC would have a greater vasoconstrictor response to ET-1, and (2) reduced ETBR-mediated dilation. We further hypothesized that ETBR-blockade would attenuate endothelium-dependent vasodilation in HC, but not PrEC. Microvascular reactivity was assessed by measurement of cutaneous vascular conductance responses to graded infusion of ET-1 (10-20-10-8 mol/l), ET-1 + 500 nmol/l BQ-123 (ETAR-blockade), and ET-1 + 300 nmol/l BQ-788 (ETBR-blockade), and during graded infusion of acetylcholine (ACh, 10-7-102 mmol/l) and a standardized local heating protocol with and without ETBR-inhibition. PrEC had an increased vasoconstriction response to ET-1 (P=0.02). PrEC demonstrated reduced dilation responses to selective ETBR stimulation with ET-1 (P=0.01). ETBR-inhibition augmented ET-1-mediated constriction in HC (P=0.01) but attenuated ET-1-mediated constriction in PrEC (P=0.003). ETBR-inhibition attenuated endothelium-dependent vasodilation responses to 100mmol/l ACh (P=0.04) and local heat (P=0.003) in HC but increased vasodilation (ACh: P=0.01; local heat: P=0.03) in PrEC. Women who have had preeclampsia demonstrate augmented vasoconstrictor sensitivity to ET-1, mediated by altered ETBR signaling. Furthermore, altered ETBR function contributes to diminished endothelium-dependent dilation in previously preeclamptic women.
© 2017 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  endothelial dysfunction; endothelin-1; microvascular; preeclampsia

Mesh:

Substances:

Year:  2017        PMID: 29042489      PMCID: PMC5922254          DOI: 10.1042/CS20171292

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  60 in total

1.  Noninvasive assessment of endothelial function in the skin microcirculation.

Authors:  Haythem Debbabi; Philippe Bonnin; Pierre Henri Ducluzeau; Georges Lefthériotis; Bernard I Levy
Journal:  Am J Hypertens       Date:  2010-02-18       Impact factor: 2.689

2.  Endothelial dysfunction and vascular stiffness in women with previous pregnancy complicated by early or late pre-eclampsia.

Authors:  R Orabona; E Sciatti; E Vizzardi; I Bonadei; A Valcamonico; M Metra; T Frusca
Journal:  Ultrasound Obstet Gynecol       Date:  2017-01       Impact factor: 7.299

3.  Gender differences in the expression of endothelin receptors in human saphenous veins in vitro.

Authors:  A Ergul; K Shoemaker; D Puett; R L Tackett
Journal:  J Pharmacol Exp Ther       Date:  1998-05       Impact factor: 4.030

4.  Effect of local warming on forearm reactive hyperaemia.

Authors:  J M Johnson; D S O'Leary; W F Taylor; W Kosiba
Journal:  Clin Physiol       Date:  1986-08

5.  Pharmacological curve fitting to analyze cutaneous adrenergic responses.

Authors:  Megan M Wenner; Thad E Wilson; Scott L Davis; Nina S Stachenfeld
Journal:  J Appl Physiol (1985)       Date:  2011-08-25

6.  Endothelin B receptor contribution to peripheral microvascular function in women with polycystic ovary syndrome.

Authors:  Megan M Wenner; Hugh S Taylor; Nina S Stachenfeld
Journal:  J Physiol       Date:  2011-08-08       Impact factor: 5.182

7.  Cardiovascular risk factors in women 10 years post early preeclampsia: the Preeclampsia Risk EValuation in FEMales study (PREVFEM).

Authors:  José T Drost; Ganiye Arpaci; Jan Paul Ottervanger; Menko Jan de Boer; Jim van Eyck; Yvonne T van der Schouw; Angela H E M Maas
Journal:  Eur J Prev Cardiol       Date:  2011-08-22       Impact factor: 7.804

8.  Vascular dysfunction in women with a history of preeclampsia and intrauterine growth restriction: insights into future vascular risk.

Authors:  Yoav Yinon; John C P Kingdom; Ayodele Odutayo; Rahim Moineddin; Sascha Drewlo; Vesta Lai; David Z I Cherney; Michelle A Hladunewich
Journal:  Circulation       Date:  2010-10-18       Impact factor: 29.690

9.  Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1.

Authors:  Babbette LaMarca; Marc Parrish; Lillian Fournier Ray; Sydney R Murphy; Lyndsay Roberts; Porter Glover; Gerd Wallukat; Katrin Wenzel; Kathy Cockrell; James N Martin; Michael J Ryan; Ralf Dechend
Journal:  Hypertension       Date:  2009-08-24       Impact factor: 10.190

Review 10.  Pre-eclampsia: pathophysiology, diagnosis, and management.

Authors:  Jennifer Uzan; Marie Carbonnel; Olivier Piconne; Roland Asmar; Jean-Marc Ayoubi
Journal:  Vasc Health Risk Manag       Date:  2011-07-19
View more
  14 in total

Review 1.  Residual vascular dysfunction in women with a history of preeclampsia.

Authors:  Anna E Stanhewicz
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-08-22       Impact factor: 3.619

2.  Local angiotensin-(1-7) administration improves microvascular endothelial function in women who have had preeclampsia.

Authors:  Anna E Stanhewicz; Lacy M Alexander
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-10-02       Impact factor: 3.619

3.  Acute systemic inhibition of inflammation augments endothelium-dependent dilation in women with a history of preeclamptic pregnancy.

Authors:  Anna E Stanhewicz; Gabrielle A Dillon; Corinna Serviente; Lacy M Alexander
Journal:  Pregnancy Hypertens       Date:  2021-12-28       Impact factor: 2.899

4.  Women with a history of preeclampsia have preserved sensory nerve-mediated dilatation in the cutaneous microvasculature.

Authors:  Michael Pyevich; Lacy M Alexander; Anna E Stanhewicz
Journal:  Exp Physiol       Date:  2022-01-09       Impact factor: 2.969

5.  Contributions of endothelin-1 and l-arginine to blunted cutaneous microvascular function in young, black women.

Authors:  John D Akins; Rauchelle E Richey; Jeremiah C Campbell; Zachary T Martin; Guillermo Olvera; R Matthew Brothers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-12-17       Impact factor: 4.733

6.  ETB receptor-mediated vasodilation is regulated by estradiol in young women.

Authors:  Leena N Shoemaker; Katherine M Haigh; Andrew V Kuczmarski; Shane J McGinty; Laura M Welti; Joshua C Hobson; David G Edwards; Ronald F Feinberg; Megan M Wenner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-08-20       Impact factor: 5.125

Review 7.  Sex-Specific Contributions of Endothelin to Hypertension.

Authors:  Eman Y Gohar; David M Pollock
Journal:  Curr Hypertens Rep       Date:  2018-06-08       Impact factor: 5.369

Review 8.  Maternal microvascular dysfunction during preeclamptic pregnancy.

Authors:  Anna E Stanhewicz; Virginia R Nuckols; Gary L Pierce
Journal:  Clin Sci (Lond)       Date:  2021-05-14       Impact factor: 6.876

9.  Microvascular Disease and Small-Vessel Disease: The Nexus of Multiple Diseases of Women.

Authors:  Hena Patel; Neelum T Aggarwal; Anupama Rao; Elizabeth Bryant; Rupa M Sanghani; Mary Byrnes; Dinesh Kalra; Leigh Dairaghi; Lynne Braun; Sherine Gabriel; Annabelle Santos Volgman
Journal:  J Womens Health (Larchmt)       Date:  2020-02-19       Impact factor: 2.681

Review 10.  Androgens in maternal vascular and placental function: implications for preeclampsia pathogenesis

Authors:  Sathish Kumar; Geoffrey H Gordon; David H Abbott; Jay S Mishra
Journal:  Reproduction       Date:  2018-10-16       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.